[Modern therapeutic strategies in stomach cancer].

H. Wilke(Heidelberg University), S. Seeber, U. Fink, P. Preusser(University Hospital Münster), Meyer Hj, Hans‐Joachim Schmoll(Martin Luther University Halle-Wittenberg), Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)

PubMed

March 1, 1991

Cited by 0

Related Papers

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

|Annals of Oncology|2012|1.5k

Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

|Journal of Clinical Oncology|2010|714

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

|The Lancet Oncology|2012|526

Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis

|Genes & Development|2009|351

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

|Annals of Oncology|2016|344